search

EmailPrintRSS Feeds

POSTERS: Biomarkers and Pharmaceutical Care

Metaxas C et al. Oral versus intramuscular vitamin B12 substitution: The patient preferences; Presented at the working Symposium of the Pharmaceutical Care Network Europe (PCNE) in Mechelen (Belgium), 4-6 February 2015 POSTER

Metaxas C et al.
Vitamin B12 associated biomarkers in metformin treated type 2 diabetes patients; Presented at the 43th ESCP Symposium on Clinical Pharmacy in Copenhagen (Denmark), 22-24 Oct 2014 POSTER

Metaxas C et al. Oral vs. Intramuscular Vitamin B12 Supplementation: Biomarker Response and Patients’ Preferences – A Study Design; Presented at the Swiss Pharma Science Day (SPSD) in Bern (Switzerland), 20 Aug 2014 POSTER

Walter P et al. Aspirin resistance and associated factors in outpatients with monitored compliance; Presented at the Swiss MedLab 2012 Congress of the Swiss Union of Laboratory Medicine (SULM) in Bern (Switzerland), 12-14 June 2012 POSTER

Walter P et al. Clinical factors are more frequently related to persistence of in vitro platelet aggregation with clopidogrel than CYP2C19 loss of function polymorphisms; Presented at the 80th SGIM Annual meeting (Schweizerische Gesellschaft für Allgemeine Innere Medizin) in Basel (Switzerland), 23-25 May 2012 POSTER

Walter P et al. Temporal pattern of compliance and its association with drug effectiveness in vascular risk patients; Presented at the 1st Swiss Pharmacy Congress in Interlaken (Switzerland), 30 Nov - 1st Dec 2011 POSTER

Walter P et al. CYP2C19 genotype is not the sole predictor of clopidogrel response as measured with in vitro platelet aggregation; Presented at the SSCC Annual Assembly & Tri-National Congress of Laboratory Medicine in Zurich (Switzerland), 2-4 Nov 2011 POSTER

Walter P et al. Temporal pattern of compliance in vascular risk patients and its association with LDL-C target attainment; Presented at the 40th ESCP Symposium on Clinical Pharmacy in Dublin (Ireland), 19-21 Oct 2011 POSTER

Messerli M et al. Prevalence of unreached cardiometabolic targets among treated patients - subanalysis of data from a community pharmacy screening campaign in Switzerland; Presented at the 7th working conference of the Pharmaceutical Care Network Europe (PCNE) in Manchester (United Kingdom), 23-26 March 2011 POSTER

Walter P et al. Prevalence of unreached biomarker targets under antihypertensive and lipid-modifying therapy in community pharmacies in Switzerland; Presented at the European Symposium on Clinical Pharmacy (ESCP) in Lyon (France), 21-23 Oct 2010 POSTER

Walter P et al. Combination of pharmacological biomarkers and compliance monitoring to detect contributing factors to drug resistance - A study design; Presented at the Swiss Pharma Science Day (SPSD) in Berne (Switzerland), 8 Sept 2010 POSTER